机构

• 上海药物研究所 [15]
• 金属研究所 [2]
• 生物物理研究所 [1]
• 物理研究所 [1]
• 福建物质结构研究所 [1]
• 上海神经科学研究所 [1]
• 更多

采集方式

• OAI收割 [24]

内容类型

• 期刊论文 [24]

发表日期

• 2019 [1]
• 2018 [1]
• 2017 [4]
• 2015 [1]
• 2014 [3]
• 2013 [2]
• 更多

学科主题

• Biochemist... [1]
• Chemistry,... [1]
• Neuroscien... [1]
• Oncology [1]

筛选

浏览/检索结果: 共24条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序提交时间升序提交时间降序作者升序作者降序发表日期升序发表日期降序 Activation and function of receptor tyrosine kinases in human clear cell renal cell carcinomas 期刊论文  OAI收割 BMC CANCER, 2019, 卷号: 19, 期号: 1, 页码: 13 作者:  Zhang, Qing;  Liu, Jian-He;  Liu, Jing-Li;  Qi, Chun-Ting;  Yan, Lei   |  收藏  |  浏览/下载：76/0  |  提交时间：2020/07/01 Receptor tyrosine kinases (RTKs)  Activation and function  Clear cell renal cell carcinomas (ccRCCs)  Targeted therapy  PDGFR beta  Stroma cells   PBA2 exhibits potent anti-tumor activity via suppression of VEGFR2 mediated-cell proliferation and angiogenesis 期刊论文  OAI收割 BIOCHEMICAL PHARMACOLOGY, 2018, 卷号: 150, 页码: 131-140 作者:  Fang, Xiaona;  Xie, Hua;  Luo, Min;  Chen, Zhen;  Wang, Fang   |  收藏  |  浏览/下载：44/0  |  提交时间：2019/01/08 Angiogenesis  And-tumor activity  Multi-tyrosine kinases inhibitor  PBA2  VEGFR2   Evaluation of in vitro and in vivo activity of a multityrosine kinase inhibitor, AL3810, against human thyroid cancer 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2017, 卷号: 38, 期号: 11, 页码: 1533-1542 作者:  Xie, Qin;  Chen, Hui;  Ai, Jing;  Gao, Ying-lei;  Geng, Mei-yu   |  收藏  |  浏览/下载：27/0  |  提交时间：2019/01/08 thyroid cancer  AL3810  multi-tyrosine kinases inhibitor  angiogenesis  RET   Synthesis and Activity Evaluation of Novel 3,4-Dihydro-benzo[b]-oxazepin-5(2H)-one Derivatives as Protein Kinases Inhibitors 期刊论文  OAI收割 CHINESE JOURNAL OF ORGANIC CHEMISTRY, 2017, 卷号: 37, 期号: 6, 页码: 1463-1472 作者:  Hou Guige;  Jiang Chengshi;  Liu Hongchun;  Tong Linjiang;  Peng Xia   |  收藏  |  浏览/下载：37/0  |  提交时间：2019/01/08 3,4-dihydro-benzo[b]oxazepin-5(2H)-one derivatives  synthesis  protein-tyrosine kinases inhibitors  ErbB1  ErbB2   Concomitant inhibition of receptor tyrosine kinases and downstream AKT synergistically inhibited growth of KRAS/BRAF mutant colorectal cancer cells 期刊论文  OAI收割 ONCOTARGET, 2017, 卷号: 8, 期号: 3, 页码: 5003-5015 作者:  Song, Qiaoling;  Sun, Xiaoxiao;  Guo, Hui;  Yu, Qiang   |  收藏  |  浏览/下载：29/0  |  提交时间：2019/01/08 receptor tyrosine kinases  AKT  colorectal cancer  drug combination  RAS/RAF   evaluationofinvitroandinvivoactivityofamultityrosinekinaseinhibitoral3810againsthumanthyroidcancer 期刊论文  OAI收割 actapharmacologicasinica, 2017, 卷号: 38, 期号: 11, 页码: 1533 作者:  Xie Qin;  Chen Hui;  Al Jing;  Gao Yinglei;  Geng Meiyu   |  收藏  |  浏览/下载：21/0  |  提交时间：2020/07/01 TARGETED THERAPIES  RET  CARCINOMA  MODELS  GROWTH  TUMORS  CELLS  thyroid cancer  AL3810  multi-tyrosine kinases inhibitor  angiogenesis  RET   Design, Synthesis and Antitumor Activity of Novel 6,7-Dimethoxyquinazoline Derivatives Containing Diaryl Urea Moiety 期刊论文  OAI收割 CHEMICAL RESEARCH IN CHINESE UNIVERSITIES, 2015, 卷号: 31, 期号: 5, 页码: 766-773 作者:  Hou Yunlei;  Wu Shasha;  Ma Longsheng;  Bai Jinying;  Liu Zijian   |  收藏  |  浏览/下载：59/0  |  提交时间：2021/02/02 RECEPTOR TYROSINE KINASES  BIOLOGICAL EVALUATION  HIGHLY POTENT  INHIBITOR  IDENTIFICATION  GROWTH  DISCOVERY  SORAFENIB  EGFR  6,7-Dimethoxyquinazoline derivative  Diaryl urea scaffold  Cytotoxic activity   HSP90 inhibitor AUY922 abrogates up-regulation of RTKs by mTOR inhibitor AZD8055 and potentiates its antiproliferative activity in human breast cancer 期刊论文  OAI收割 INTERNATIONAL JOURNAL OF CANCER, 2014, 卷号: 135, 期号: 10, 页码: 2462-2474 作者:  Chen, Si-Meng;  Guo, Chen-Liang;  Shi, Jia-Jie;  Xu, Yi-Chao;  Chen, Yi   |  收藏  |  浏览/下载：25/0  |  提交时间：2019/01/08 mTOR kinase inhibitor  HSP90 inhibitor  breast cancer  receptor tyrosine kinases  drug combination   Chemical Constituents from the Heartwood of Haematoxylon campechianum as Protein Tyrosine Kinase Inhibitors 期刊论文  OAI收割 CHEMISTRY & BIODIVERSITY, 2014, 卷号: 11, 期号: 5, 页码: 776-783 作者:  Lin, Li-Gen;  Xie, Hua;  Wang, Yi-Tao;  Ding, Jian;  Ye, Yang   |  收藏  |  浏览/下载：30/0  |  提交时间：2019/01/08 Haematoxylon campechianum  Protein tyrosine kinases (PTKs)  Epihematoxylol B  Homoisoflavonoids  Hematoxylol B  10-O-methyl-  Kinase insert domain receptor (KDR)   Aqueous extract of Taxus Chinensis (Pilger) Rehd inhibits lung carcinoma A549 cells through the epidermal growth factor receptor/mitogen-activated protein kinase pathway in vitro and in vivo 期刊论文  OAI收割 JOURNAL OF TRADITIONAL CHINESE MEDICINE, 2014, 卷号: 34 -   |  收藏  |  浏览/下载：17/0  |  提交时间：2020/10/26 PHARMACOLOGICAL TESTING METHOD  VAR. MAIREI  TYROSINE PHOSPHORYLATION  HUMAN TUMORS  CANCER  EXPRESSION  THERAPY  MAPK  PROLIFERATION  Taxus  Lung neoplasms  Receptor  epidermal growth factor  Mitogen-activated protein kinases  In vitro  In vivo